Latest Close
₹5,079.00
+0.02%
Connecting…
Day Range
-
Full OHLC pending
Volume
-
Full session data pending
50 DMA
₹5,366.10
200 DMA
₹5,478.75
1 year gain / loss
−₹446.00(-8.07%)
₹5,525.00 → ₹5,079.00· 2025-10-30 to 2026-10-30
Charting by TradingView
This stock does not satisfy the default swing-support rules at the selected chart endpoint. Its price, volume and moving averages remain available for manual research.
Snapshot 2026-10-31 · Financial period Jun 2026 · Consolidated figures where available
Alkem Laboratories Ltd. is an India-based pharmaceutical company engaged in the development, manufacturing, and sale of pharmaceutical products. The Company operates in a single business segment-Pharmaceuticals. It produces branded generics, generic drugs, active pharmaceutical ingredients (APIs), and nutraceuticals, which it markets in India and international markets. It has a portfolio of approximately 800 brands in India and maintains a presence in over 40 international markets, with the United States being its key focus market. Its offerings include therapies, prescription (Rx) products, and Alkem generics. Its therapy offerings cover multiple medical fields, including anti-infectives, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory care, rheumatology, and urology. The Company’s subsidiaries include Ascend Laboratories (Pty) Ltd, Pharmacor Pty Limited, Alkem Laboratories Corporation, and others.
Market Cap
₹61,277.06 Cr
P/E
27.80×
Sector -38.72× · above
P/B
4.43×
Sector 4.11× · above
EV / EBITDA
17.84×
Sector 22.21× · below
ROE
16.66%
Sector 0.31%
ROCE
18.61%
Sector 6.48%
ROA
10.57%
Sector -17.12%
Cash Flow / Profit
0.83×
| Period | Revenue | Operating profit | Net profit |
|---|---|---|---|
| Jun 2026 | 3,892.9 +2.4% | 771.99 | 521.49 +107.2% |
| Mar 2026 | 3,803.39 -2.0% | 422.85 | 251.68 -61.5% |
| Dec 2025 | 3,879.92 -5.5% | 781.2 | 653.53 -16.2% |
| Sep 2025 | 4,104.68 | 895.83 | 779.6 |
Dividend
07 Aug 2026 · ₹10
Dividend
20 Feb 2026 · ₹43